Vallon Pharmaceuticals - Stock Price History | VLON

Historical daily share price chart and data for Vallon Pharmaceuticals since 2021 adjusted for splits. The latest closing stock price for Vallon Pharmaceuticals as of September 27, 2021 is 7.00.
  • The all-time high Vallon Pharmaceuticals stock closing price was 9.68 on September 09, 2021.
  • The Vallon Pharmaceuticals 52-week high stock price is 10.36, which is 48% above the current share price.
  • The Vallon Pharmaceuticals 52-week low stock price is 3.61, which is 48.4% below the current share price.
  • The average Vallon Pharmaceuticals stock price for the last 52 weeks is 5.20.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Vallon Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.048B $0.000B
Vallon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of novel drugs which are designed to deter abuse in the treatment of CNS disorders. Vallon Pharmaceuticals Inc. is based in PHILADELPHIA, PA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29